Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis

Medical Journal of Malaysia

Volumn 59, Issue 3, 2004, Pages 391-394

  Selim, K ^a   Hüseyin, Caksen ^b   Ibrahim, K H ^a   Hasan, B U ^a   Kazim, U ^a   Huseyin K ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Newborn; Pentoxifylline; Sepsis

Indexed keywords

C REACTIVE PROTEIN; ENZYME INHIBITOR; INTERLEUKIN 6; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIRTH WEIGHT; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GESTATIONAL AGE; HUMAN; MALE; METABOLISM; NEWBORN; RANDOMIZED CONTROLLED TRIAL; SEPSIS;

BIRTH WEIGHT; C-REACTIVE PROTEIN; ENZYME INHIBITORS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTERLEUKIN-6; MALE; PENTOXIFYLLINE; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18444379362     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Alkharfy KM, Kellum JA, Matzke GR. Unintended immunomodulation: part II. Effects of pharmacological agents on cytokine activity. Shock 2000; 13: 346-60.
2. Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol 1994; 30: 603-21.
3. Mandi Y, Farkas G, Ocsovszky I, Nagy Z. Inhibition of tumor necrosis factor production and ICAM-1 expression by pentoxifylline: beneficial effects in sepsis syndrome. Res Exp Med (Berl) 1995; 195: 297-307.
4. Zeni F, Pain P, Vindimian M, Gay JP, et al. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med 1996; 24: 207-14.
5. Lauterbach R, Zembala M. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Eur J Pediatr 1996; 155: 404-9.
6. Lauterbach R, Pawlik D, Kowalczyk D, Ksycinski W, Helwich E, Zembala M. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med 1999; 27: 807-14.
7. Harris MC, Costarino AT Jr, Sullivan JS, et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 1994; 124: 105-11.
8. de Bont ES, Martens A, van Raan J, et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis. Pediatr Res 1993; 33: 380-3.
9. de Bont ES, Martens A, van Raan J, et al. Diagnostic value of plasma levels of tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) in newborns with sepsis. Acta Paediatr 1994; 83: 696-9.
10. Silveira RC, Procianoy RS. Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis. Acta Paediatr 1999; 88: 647-50.
11. Zabel P, Schade FU. Therapeutic strategies against mediators of septic shock (text in German with English abstract). Immun Infekt 1993; 21: 45-50.